You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

Not yet recruiting
  • First-line Treatment of Non-clear Renal Cell Carcinoma
  • Fruquintinib combined with Serplulimab
  • (no location specified)
Apr 16, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 6, 2023

Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab infusion
  • Lenvatinib tablet
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Feb 8, 2023

Renal Cell Carcinoma Trial in Haifa (PROSENSE™)

Active, not recruiting
  • Renal Cell Carcinoma
  • PROSENSE™
  • Haifa, Israel
  • +1 more
Dec 21, 2022

Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

Completed
  • Carcinoma, Renal Cell
  • We do not have any interventions. This study is based on obseravation.
  • (no location specified)
Oct 27, 2023

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))

Not yet recruiting
  • Renal Cell Carcinoma (RCC)
  • Trans-arterial embolization (TAE)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 5, 2022

Renal Cell Carcinoma Metastases to Pancreas

Completed
  • Surgery
    • (no location specified)
    May 21, 2023

    Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +11 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Carcinoma, Renal Cell Trial (Orellanine)

    Not yet recruiting
    • Carcinoma, Renal Cell
    • (no location specified)
    Jan 25, 2023

    Develop Circulating Exosomes as Predictive Biomarkers for

    Recruiting
    • Renal Cell Carcinoma
    • Other: Blood and Urine Collection
    • Hangzhou, China
      An Zhao
    Jan 30, 2023

    Fumarate Hydratase Deficient Renal Cell Carcinoma Trial (Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Fumarate Hydratase Deficient Renal Cell Carcinoma
    • (no location specified)
    May 18, 2023

    Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Perfusion CT scan
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 6, 2022

    Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant
    • Axitinib plus Toripalimab
    • radical nephrectomy
    • (no location specified)
    Feb 12, 2023

    Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

    Recruiting
    • Non-clear Renal Cell Carcinoma
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 13, 2023

    Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

    Recruiting
    • Renal Cancer
    • +2 more
      • Amsterdam, Noord Holland, Netherlands
        Amsterdam UMC locatie VUMC
      Jan 20, 2023

      go Back Into Records and Observe How People With Metastatic

      Not yet recruiting
      • Carcinoma, Renal Cell
      • Clear-cell Metastatic Renal Cell Carcinoma
      • Istanbul, Turkey
        Pfizer
      Feb 15, 2023

      Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

      Active, not recruiting
      • Metastatic Renal Cell Carcinoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Jan 25, 2023

      Primary and Metastatic Tumors in Renal Cell Carcinoma and

      Recruiting
      • Renal Cell Carcinoma
      • +4 more
      • Immune checkpoint inhibitor targeting PD1
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center - Philadelphia
      Jan 27, 2023

      Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

      Recruiting
      • Kidney Cancer
      • +2 more
      • Cytoreductive nephrectomy±metastasectomy
      • Human-derived materials sampling
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Mar 2, 2023

      Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

      Completed
      Has Results
      • Carcinoma
      • Renal Cell
      • London, United Kingdom
        Pfizer UK
      Jan 9, 2023

      Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

      Recruiting
      • Non-Clear Cell Renal Cell Carcinoma
      • Duarte, California
        Exelixis Clinical Site #1
      Jan 13, 2023

      Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,

      Not yet recruiting
      • Renal Cell Carcinoma
      • Neoadjuvant Lenvatinib
      • +3 more
      • (no location specified)
      Dec 23, 2022

      Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • (no location specified)
      May 14, 2023

      CaboCHECK - Cabozantinib in Adult Advanced Renal Cell Carcinoma

      Terminated
      • Advanced Renal Cell Carcinoma (All Subtypes)
      • Metastatic Renal Cell Carcinoma (All Subtypes)
      • Documentation
      • Essen, Nordrhein-Westfalen, Germany
      • +1 more
      Dec 21, 2022